The preconception care experiences of women with epilepsy on sodium valproate

Lorna Lawther*, Helen Dolk, Marlene Sinclair, Jim Morrow

*Corresponding author for this work

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose: To understand the preconception experiences of women with epilepsy who have been taking the teratogenic drug valproate. Methods: Seven women were recruited, three from a preconception clinic and four from an antenatal clinic in a region of the UK. All had taken valproate preconceptionally. Three preconception clinic encounters were observed and audio-recorded. Interviews with all women were analysed using Interpretative Phenomenological Analysis (IPA). Results: Women experienced a “trajectory of balance”. Women moved from “maintaining balance” by using valproate to control seizures, to a “shattering of harmony” at the prospect of changing medication and as a result of the physical and mental effects of changing medication, to “restoring balance” which could involve “a new self” due to dramatic changes. Women balanced their health needs with those of their baby, and took responsibility for medication decision-making. They found it difficult to see “who is looking after me” in the healthcare system, either to access preconception care, or to support them through the stress of changing medication. Their journey ended with coming to terms with a variety of experiences: choosing not to have a baby due to unsuccessful change from valproate, recognising that a child from a previous pregnancy had been harmed by valproate or that the current pregnancy might be at risk, or successful medication change in preparation for pregnancy. Conclusion: A clear and adequately funded preconception care pathway is needed from epilepsy diagnosis, including support for stress. Understanding what influences maternalisation may help understand uptake of preconception care.

Original languageEnglish
Pages (from-to)82-89
JournalSeizure
Volume59
DOIs
Publication statusPublished - 01 Jul 2018

Fingerprint

Preconception Care
Valproic Acid
Epilepsy
Pregnancy
Decision Making
Seizures
Interviews
Delivery of Health Care
Health

Keywords

  • Decision-making
  • Epilepsy
  • Interpretative phenomenological analysis
  • Preconception care
  • Pregnancy
  • Sodium valproate

Cite this

Lawther, Lorna ; Dolk, Helen ; Sinclair, Marlene ; Morrow, Jim. / The preconception care experiences of women with epilepsy on sodium valproate. In: Seizure. 2018 ; Vol. 59. pp. 82-89.
@article{994d855345ce4f9993cd480072e64f4e,
title = "The preconception care experiences of women with epilepsy on sodium valproate",
abstract = "Purpose: To understand the preconception experiences of women with epilepsy who have been taking the teratogenic drug valproate. Methods: Seven women were recruited, three from a preconception clinic and four from an antenatal clinic in a region of the UK. All had taken valproate preconceptionally. Three preconception clinic encounters were observed and audio-recorded. Interviews with all women were analysed using Interpretative Phenomenological Analysis (IPA). Results: Women experienced a “trajectory of balance”. Women moved from “maintaining balance” by using valproate to control seizures, to a “shattering of harmony” at the prospect of changing medication and as a result of the physical and mental effects of changing medication, to “restoring balance” which could involve “a new self” due to dramatic changes. Women balanced their health needs with those of their baby, and took responsibility for medication decision-making. They found it difficult to see “who is looking after me” in the healthcare system, either to access preconception care, or to support them through the stress of changing medication. Their journey ended with coming to terms with a variety of experiences: choosing not to have a baby due to unsuccessful change from valproate, recognising that a child from a previous pregnancy had been harmed by valproate or that the current pregnancy might be at risk, or successful medication change in preparation for pregnancy. Conclusion: A clear and adequately funded preconception care pathway is needed from epilepsy diagnosis, including support for stress. Understanding what influences maternalisation may help understand uptake of preconception care.",
keywords = "Decision-making, Epilepsy, Interpretative phenomenological analysis, Preconception care, Pregnancy, Sodium valproate",
author = "Lorna Lawther and Helen Dolk and Marlene Sinclair and Jim Morrow",
year = "2018",
month = "7",
day = "1",
doi = "10.1016/j.seizure.2018.05.003",
language = "English",
volume = "59",
pages = "82--89",
journal = "Seizure-European journal of epilepsy",
issn = "1059-1311",
publisher = "W.B. Saunders Ltd",

}

The preconception care experiences of women with epilepsy on sodium valproate. / Lawther, Lorna; Dolk, Helen; Sinclair, Marlene; Morrow, Jim.

In: Seizure, Vol. 59, 01.07.2018, p. 82-89.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The preconception care experiences of women with epilepsy on sodium valproate

AU - Lawther, Lorna

AU - Dolk, Helen

AU - Sinclair, Marlene

AU - Morrow, Jim

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Purpose: To understand the preconception experiences of women with epilepsy who have been taking the teratogenic drug valproate. Methods: Seven women were recruited, three from a preconception clinic and four from an antenatal clinic in a region of the UK. All had taken valproate preconceptionally. Three preconception clinic encounters were observed and audio-recorded. Interviews with all women were analysed using Interpretative Phenomenological Analysis (IPA). Results: Women experienced a “trajectory of balance”. Women moved from “maintaining balance” by using valproate to control seizures, to a “shattering of harmony” at the prospect of changing medication and as a result of the physical and mental effects of changing medication, to “restoring balance” which could involve “a new self” due to dramatic changes. Women balanced their health needs with those of their baby, and took responsibility for medication decision-making. They found it difficult to see “who is looking after me” in the healthcare system, either to access preconception care, or to support them through the stress of changing medication. Their journey ended with coming to terms with a variety of experiences: choosing not to have a baby due to unsuccessful change from valproate, recognising that a child from a previous pregnancy had been harmed by valproate or that the current pregnancy might be at risk, or successful medication change in preparation for pregnancy. Conclusion: A clear and adequately funded preconception care pathway is needed from epilepsy diagnosis, including support for stress. Understanding what influences maternalisation may help understand uptake of preconception care.

AB - Purpose: To understand the preconception experiences of women with epilepsy who have been taking the teratogenic drug valproate. Methods: Seven women were recruited, three from a preconception clinic and four from an antenatal clinic in a region of the UK. All had taken valproate preconceptionally. Three preconception clinic encounters were observed and audio-recorded. Interviews with all women were analysed using Interpretative Phenomenological Analysis (IPA). Results: Women experienced a “trajectory of balance”. Women moved from “maintaining balance” by using valproate to control seizures, to a “shattering of harmony” at the prospect of changing medication and as a result of the physical and mental effects of changing medication, to “restoring balance” which could involve “a new self” due to dramatic changes. Women balanced their health needs with those of their baby, and took responsibility for medication decision-making. They found it difficult to see “who is looking after me” in the healthcare system, either to access preconception care, or to support them through the stress of changing medication. Their journey ended with coming to terms with a variety of experiences: choosing not to have a baby due to unsuccessful change from valproate, recognising that a child from a previous pregnancy had been harmed by valproate or that the current pregnancy might be at risk, or successful medication change in preparation for pregnancy. Conclusion: A clear and adequately funded preconception care pathway is needed from epilepsy diagnosis, including support for stress. Understanding what influences maternalisation may help understand uptake of preconception care.

KW - Decision-making

KW - Epilepsy

KW - Interpretative phenomenological analysis

KW - Preconception care

KW - Pregnancy

KW - Sodium valproate

U2 - 10.1016/j.seizure.2018.05.003

DO - 10.1016/j.seizure.2018.05.003

M3 - Article

C2 - 29778017

AN - SCOPUS:85047207860

VL - 59

SP - 82

EP - 89

JO - Seizure-European journal of epilepsy

JF - Seizure-European journal of epilepsy

SN - 1059-1311

ER -